TY - JOUR
KW - Leishmaniasis
KW - Neglected tropical diseases (NTDs)
KW - antileishmanial drug discovery
KW - N-myristoyltransferase (NMT) inhibitors
KW - natural products
KW - quinoline-4-carboxylic acids,
KW - host-directed therapy
AU - Kalesh K
AU - Barbosa EG
AU - Jordão AK
BT - Frontiers in Pharmacology
DO - 10.3389/fphar.2025.1718438
LA - ENG
M3 - Article
PB - Frontiers Media SA
PY - 2025
SP - 1
EP - 4
T2 - Frontiers in Pharmacology
TI - Editorial: Drug discovery for leishmaniasis and chagas disease: compound design and therapeutic strategies
UR - https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1718438/pdf
VL - 16
SN - 1663-9812
ER -